Demo Sign up Log In

Inhibrx Biosciences Inc (INBX)

Cash Conversion Ratio

1.05×

Quarterly · Period ending: Jun 30, 2025

INBX Cash Conversion Ratio

Latest reported1.05×period endingJun 30, 2025

Latest reported1.05×period endingJun 30, 2025

INBX Quarterly Cash Conversion Ratio (0.92× → 1.05×)

Latest values, visible window

High-resolution chart · PNG

INBX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibrx Biosciences Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2025	1.0453×
Dec 31, 2024	0.9137×
Jun 30, 2024	-0.0315×
Dec 31, 2023	0.6438×
Sep 30, 2023	1.0631×
Jun 30, 2023	0.9057×
Mar 31, 2023	0.5537×
Dec 31, 2022	0.7544×
Sep 30, 2022	0.7582×
Jun 30, 2022	0.722×
Mar 31, 2022	0.8657×
Dec 31, 2021	1.0801×
Sep 30, 2021	0.6727×
Jun 30, 2021	1.1006×
Mar 31, 2021	1.123×
Dec 31, 2020	0.9066×
Sep 30, 2020	0.6919×
Jun 30, 2020	0.6526×
Mar 31, 2020	0.3722×
Dec 31, 2019	0.753×
Sep 30, 2019	0.0736×
Jun 30, 2019	1.3057×
Mar 31, 2019	1.4697×
Dec 31, 2018	1.7053×
Jun 30, 2018	1.889×
Mar 31, 2018	0.234×
Dec 31, 2017	0.9163×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.